Conflict of interest: C.P. received consultant and speaker fees from Acticor Biotech, Amgen, Bayer, Eli Lilly, Tremeau, Zambon, and grant support (to the institution) for investigator-initiated research from AIFA (Italian Drug Agency), Bayer, Cancer Research UK, and European Commission; he chairs the Scientific Advisory Board of the International Aspirin Foundation.